HomeVRDN • NASDAQ
Viridian Therapeutics Inc
add
In the news
Financials
Income Statement
Revenue
Net Income
Revenue
Net income
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Revenue | 70.57M | 81,958.14% |
Operating expense | 24.32M | 68.81% |
Net income | -34.60M | 54.88% |
Net profit margin | -49.03 | 99.95% |
Earnings per share | -0.34 | 70.43% |
EBITDA | -39.90M | 52.13% |
Effective tax rate | — | — |
Balance Sheet
Total Assets
Total Liabilities
Total assets
Total liabilities
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 490.90M | -34.83% |
Total assets | 577.14M | -25.23% |
Total liabilities | 74.17M | 15.16% |
Total equity | 502.97M | — |
Shares outstanding | 95.44M | — |
Price to book | 7.48 | — |
Return on assets | -17.25% | — |
Return on capital | -18.78% | — |
Cash Flow
Net Change in Cash
Net change in cash
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Net income | -34.60M | 54.88% |
Cash from operations | -84.61M | -24.97% |
Cash from investing | 126.08M | 248.91% |
Cash from financing | 10.86M | -95.57% |
Net change in cash | 52.32M | -43.53% |
Free cash flow | -72.87M | -84.57% |
Previous close
$28.59
Day range
$28.33 - $29.00
Year range
$9.90 - $29.58
Market cap
2.74B USD
Avg Volume
1.74M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
About
Founded
2010
Headquarters
Website
Employees
143
